학술논문

The Presence of Wild-Type TP53 Is Necessary for the Radioprotective Effect of the Bowman-Birk Proteinase Inhibitor in Normal Fibroblasts
Document Type
research-article
Source
Radiation Research, 1998 Dec 01. 150(6), 648-655.
Subject
Fibroblasts
Cell cycle
Irradiation
Cell lines
Exons
Transformed cell line
Genetic mutation
Polymerase chain reaction
Interphase
Protease inhibitors
Language
English
ISSN
00337587
19385404
Abstract
In the present study we have demonstrated that the Boman-Birk proteinase inhibitor (BBI) protected normal fibroblasts from a radiation-induced reduction in cell survival, whereas in transformed fibroblasts no radioprotective effect was observed. It was shown that BBI reduced the radiation-induced protein stabilization and DNA-binding activity of TP53 (formerly known as p53) in normal fibroblasts. In transformed fibroblasts, BBI failed to induce these effects. The analysis of the TP53 gene in transformed fibroblasts revealed a mutation in exon 5. As a consequence of this mutation, the expression of the TP53 downstream gene CDKN1A (p21/WAF1/Cip1) is blocked. Based on experiments using TP53 antisense oligonucleotides, the radioprotective effect of BBI could be correlated with the function of wild-type TP53. Thus BBI can be considered as a selective radioprotective agent for normal human fibroblasts.